Prolonged use of topical antibiotics occasionally may result in overgrowth of nonsusceptible micro-organisms. lf this occurs or if irritation, sensitization or superinfection develops with the use of Neoderm Cream, treatment should be discontinued and appropriate therapy instituted.
Cross-allergenicity among aminoglycosides has been demonstrated.
Any of the side effects that are reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children.
Systemic absorption of topical corticosteroids or gentamicin will be increased if extensive body surface areas are treated or if occlusive dressings are used. Application of gentamicin to open wounds or damaged skin should be avoided. Suitable precautions should be taken under these conditions, particularly in infants and children.
Long term use of gentamicin is not recommended.
Visual disturbance: Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serious chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
Neoderm Cream is not for ophthalmic use.